Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > 300 million versus 700 million shares out.
View:
Post by Maxcitrac on Dec 27, 2024 9:39am

300 million versus 700 million shares out.

I would like the complainers on this board(DumDum,NotaPoop,Mikee, Infinity....)To find a single small cap company that went from nothing to FDA BTD approval without multiple delays, and with only 300 million shares out.
EX, IBRX, ImmunityBio N803+BCG did get BTD approval for a bladder cancer treatment with much inferior data compared to Theralase Ruvidar, and did it with 700 million shares out. And ImmunityBio did experience multiple delays, just like Theralase.
700 million shares out, double Theralase shares out count,Theralase has over 300 million shares out.
Comment by N0taP00p on Dec 27, 2024 11:54am
Maxi: Your weekend homework is to study the concept of market cap and differentiate it from sharecount. Extra credit for telling us the net worth of IBRX founder and main backer. Then, wrap it all up with your perspective on you'll personally strive to be a data-driven investor in 2025 that values all input, positive and negative. Q1 2025 is almost here.  Be thinking of what you might say ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities